Newzen Pharmaceuticals Private Limited
About Newzen Pharmaceuticals Private Limited
Data last updated:
Newzen Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the service-based operations segment of the business services sector. It was incorporated on 21 July 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2016PTC303361. Its GSTIN is 07AAFCN3274R1ZT (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Chander Kumar and Brijesh Kumar.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at House No – 25 G.F. Pillar No – 02 Deepak Vihar Nilothi Extn., Delhi, India – 110041.
As per the financials filed for FY 2020, the company reported a revenue of ₹11.7 Lakh, a decline of 38% compared to the previous year. For the same year it recorded a net loss of ₹12.05 Lakh (net margin -103%) and EBITDA of -₹12.05 Lakh (EBITDA margin -103%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Newzen Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressHouse No – 25 G.F. Pillar No – 02 Deepak Vihar Nilothi Extn., Delhi, India – 110041
- IndustryBusiness Services, Other Services, Miscellaneous Business Activities
To see the full contact details of Newzen Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Newzen Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Newzen Pharmaceuticals Private Limited, buy the company report.
Financials of Newzen Pharmaceuticals Private Limited
FY 2022 filings availableNewzen Pharmaceuticals Private Limited reported revenue of ₹11.7 Lakh (down 38% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue fell 38% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ₹11.7 Lakh | |||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹12.05 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹12.05 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -103% | |||
| Net Profit Margin | -103% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Newzen Pharmaceuticals Private Limited, buy the company report.
Board of directors of Newzen Pharmaceuticals Private Limited
Newzen Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chander Kumar Also directs: Vmat Life Care Private Limited | Director | 23 Jun 2017 | 9 Years 4 Months | Current |
| Brijesh Kumar Also directs: Vmat Life Care Private Limited | Director | 15 Sep 2020 | 6 Years 1 Months | Current |
Peer comparison
Newzen Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Chairo Pharmaceuticals Private Limited | ₹11.71 Lakh (FY 2025) | 56.0% | Pune, Maharashtra, India | |||
| Prowell Pharmaceuticals Private Limited | ₹11.71 Lakh (FY 2024) | -6.0% | Kalol, Gujarat, India | |||
| Newzen Pharmaceuticals Private Limitedthis company | ₹11.7 Lakh (FY 2020) | -₹12.05 Lakh | -103% | -38.0% | Delhi, India | |
| Western Indian Pharmaceuticals (OPC) Private Limited | ₹11.69 Lakh (FY 2025) | -8.0% | Indore, Madhya Pradesh, India | |||
| Finlo Pharmaceuticals Private Limited | ₹11.68 Lakh (FY 2021) | Guwahati, Assam, India | ||||
| Confiance Pharmaceuticals Private Limited | ₹11.67 Lakh (FY 2025) | -15.0% | Madhubani, Bihar, India |
To see the full peer comparison of Newzen Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Newzen Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Newzen Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Newzen Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAFCN3274R1ZT | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Newzen Pharmaceuticals Private Limited, buy the company report.
Recent activity
Newzen Pharmaceuticals Private Limited has 4 board changes on record since 2017: 2 appointments and 2 cessations. The latest: Abhinav Singh ceased to be Director on 16 Sep 2020.
Frequently asked questions
Newzen Pharmaceuticals is an active private limited company based in Delhi, India. The company works in other services, within the business services industry. It was incorporated on 21 July 2016 (10+ years old) and is registered under CIN U74999DL2016PTC303361.
Newzen Pharmaceuticals has 2 current directors:
- Chander Kumar - Director
- Brijesh Kumar - Director
The latest financial statements of Newzen Pharmaceuticals on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Newzen Pharmaceuticals is 07AAFCN3274R1ZT, registered in Delhi.
The CIN (Corporate Identification Number) of Newzen Pharmaceuticals is U74999DL2016PTC303361. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Newzen Pharmaceuticals was incorporated on 21 July 2016, making it 10+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Newzen Pharmaceuticals by revenue are Chairo Pharmaceuticals Private Limited, Prowell Pharmaceuticals Private Limited, Western Indian Pharmaceuticals (OPC) Private Limited, Finlo Pharmaceuticals Private Limited, Confiance Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Abhinav Singh ceased to be Director on 16 Sep 2020. Brijesh Kumar was appointed as Director on 15 Sep 2020. Brijesh Kumar ceased to be Director on 01 Dec 2019. Newzen Pharmaceuticals has 4 board changes on record in total.
The registered office of Newzen Pharmaceuticals is at House No – 25 G.F. Pillar No – 02 Deepak Vihar Nilothi Extn., Delhi, India – 110041.
Newzen Pharmaceuticals operates in the business services industry, in the other services segment.
The compliance status of Newzen Pharmaceuticals is compliant as of 06 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
